Pharmaresources develops drugs and active pharmaceutical ingredient processes.
Founded in 2007 and based in Shanghai, Pharmaresources develops drugs and active pharmaceutical ingredient processes. Its products include chemical APIs and pharmaceutical intermediates, including tegrenol, oxiracetam, verapavir, and paramivir. The company also provides biopharmacology, pharmacokinetics, analytical chemistry, and computational chemistry services. Chairman and CEO Ping Chen previously worked in Squibb Pharmaceutical Company's New Drug Research and Development Department for 17 years.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in